These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9709468)

  • 1. Association of atherogenic low-density lipoprotein subfractions with carotid atherosclerosis.
    Landray MJ; Sagar G; Muskin J; Murray S; Holder RL; Lip GY
    QJM; 1998 May; 91(5):345-51. PubMed ID: 9709468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein remnants and dense LDL are associated with features of unstable carotid plaque: a flag for non-HDL-C.
    Zambon A; Puato M; Faggin E; Grego F; Rattazzi M; Pauletto P
    Atherosclerosis; 2013 Sep; 230(1):106-9. PubMed ID: 23958261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small low-density lipoprotein and small low-density lipoprotein/total low-density lipoprotein are closely associated with intima-media thickness of the carotid artery in Type 2 diabetic patients.
    Inukai T; Yamamoto R; Suetsugu M; Matsumoto S; Wakabayashi S; Inukai Y; Matsutomo R; Takebayashi K; Aso Y
    J Diabetes Complications; 2005; 19(5):269-75. PubMed ID: 16112502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between traditional cholesterol parameters, lipoprotein particle concentration, novel biomarkers and carotid plaques in retired National Football League players.
    Virani SS; Pompeii L; Lincoln AE; Dunn RE; Tucker AM; Nambi V; Nasir K; Vogel RA; Boone JL; Roberts AJ; Ballantyne CM
    Atherosclerosis; 2012 Jun; 222(2):551-6. PubMed ID: 22525822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
    Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR
    Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Oxidized Low-Density Lipoprotein Levels Independently Predict 10-Year Progression of Subclinical Carotid Atherosclerosis: A Community-Based Cohort Study.
    Gao S; Zhao D; Qi Y; Wang W; Wang M; Sun J; Liu J; Li Y; Liu J
    J Atheroscler Thromb; 2018 Oct; 25(10):1032-1043. PubMed ID: 29515051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation among lipoprotein subfractions and carotid atherosclerosis in Alaskan Eskimos (from the GOCADAN Study).
    Masulli M; Patti L; Riccardi G; Vaccaro O; Annuzzi G; Ebbesson SO; Fabsitz RR; Howard WJ; Otvos JD; Roman MJ; Wang H; Weissman NJ; Howard BV; Rivellese AA
    Am J Cardiol; 2009 Dec; 104(11):1516-21. PubMed ID: 19932785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of serum low density lipoprotein cholesterol, smoking and hypertension with different manifestations of atherosclerosis.
    Salonen JT; Salonen R
    Int J Epidemiol; 1990 Dec; 19(4):911-7. PubMed ID: 2084021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial.
    Mora S; Caulfield MP; Wohlgemuth J; Chen Z; Superko HR; Rowland CM; Glynn RJ; Ridker PM; Krauss RM
    Circulation; 2015 Dec; 132(23):2220-9. PubMed ID: 26408274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein profile in patients who survive a stroke.
    Oravec S; Krivosikova Z; Krivosik M; Gruber K; Gruber M; Dukát A; Gavorník P
    Neuro Endocrinol Lett; 2011; 32(4):496-501. PubMed ID: 21876499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between small dense LDL and early atherosclerosis in a sample of menopausal women.
    Gentile M; Panico S; Mattiello A; Ubaldi S; Iannuzzo G; De Michele M; Iannuzzi A; Rubba P
    Clin Chim Acta; 2013 Nov; 426():1-5. PubMed ID: 23994569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between low-density lipoprotein subclasses and asymptomatic atherosclerosis in subjects from the Atherosclerosis Risk in Communities (ARIC) Study.
    Hallman DM; Brown SA; Ballantyne CM; Sharrett AR; Boerwinkle E
    Biomarkers; 2004; 9(2):190-202. PubMed ID: 15370875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-density lipoprotein subfractions and cardiovascular risk in hypertension: relationship to endothelial dysfunction and effects of treatment.
    Felmeden DC; Spencer CG; Blann AD; Beevers DG; Lip GY
    Hypertension; 2003 Mar; 41(3):528-33. PubMed ID: 12623954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Low-Density Lipoprotein Cholesterol/High-Density Lipoprotein Cholesterol Concentration Ratio and Early Marker of Carotid Artery Atherosclerosis.
    Nimkuntod P; Tongdee P
    J Med Assoc Thai; 2015 May; 98 Suppl 4():S58-63. PubMed ID: 26201135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of low-dose rosuvastatin on plasma levels of cholesterol and oxidized low-density lipoprotein in 3 ultracentrifugally separated low-density lipoprotein subfractions.
    Homma K; Homma Y; Ozawa H; Shiina Y; Shibata T; Yoshida T; Hasegawa K; Kanda T; Tokuyama H; Wakino S; Hayashi K; Itoh H; Hori S
    J Clin Lipidol; 2015; 9(6):751-757. PubMed ID: 26687695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small dense low-density lipoproteins and associated risk factors in patients with stroke.
    Zhao CX; Cui YH; Fan Q; Wang PH; Hui R; Cianflone K; Wang DW
    Cerebrovasc Dis; 2009; 27(1):99-104. PubMed ID: 19033685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal Medical Management Reduces Risk of Disease Progression and Ischemic Events in Asymptomatic Carotid Stenosis Patients: A Long-Term Follow-Up Study.
    Shah Z; Masoomi R; Thapa R; Wani M; Chen J; Dawn B; Rymer M; Gupta K
    Cerebrovasc Dis; 2017; 44(3-4):150-159. PubMed ID: 28689200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in LDL receptor-mediated metabolism of three low density lipoprotein subfractions by human monocyte-derived macrophages: impact on the risk for atherosclerosis.
    de Graaf J; Hendriks JC; Swinkels DW; Demacker PN; Stalenhoef AF
    Artery; 1993; 20(4):201-30. PubMed ID: 8250739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia.
    Oravec S; Dostal E; Dukát A; Gavorník P; Kucera M; Gruber K
    Neuro Endocrinol Lett; 2011; 32(4):502-9. PubMed ID: 21876506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similarity in the distribution of F(2)-isoprostanes in the lipid subfractions of atherosclerotic plaque and in vitro oxidised low density lipoprotein.
    Waddington EI; Puddey IB; Mori TA; Croft KD
    Redox Rep; 2002; 7(3):179-84. PubMed ID: 12189049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.